References
- Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:7–15
- Wright D, Syngelaki A, Bradbury I, et al. First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing. Fetal Diagn Ther 2014;35:118–26
- Haddow JE, Palomaki GE, Canick JA, Knight GJ. Prenatat screening for open neural tube defects and Down’s syndrome. In: Rodeck CH, Whittle MJ, eds. Fetal medicine. 2nd ed. London: Churchill Livingstone; 2009 p. 243–63
- Revello R, Sarno L, Ispas A, et al. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of failed result. Ultrasound Obstet Gynecol 2016;47:698–704
- Sherod C, Sebire NJ, Soares W, et al. Prenatal diagnosis of trisomy 18 at the 10-14-week ultrasound scan. Ultrasound Obstet Gynecol 1997;10:387–90
- Tul N, Spencer K, Noble P, et al. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 1999;19:1035–42
- Spencer K, Spencer CE, Power M, et al. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG 2000;107:1271–5
- Spencer K, Spencer CE, Power M, et al. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003;110:281–6
- Wøjdemann KR, Shalmi AC, Christiansen M, et al. Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women. Ultrasound Obstet Gynecol 2005;25:227–33
- Koster MP, Stoutenbeek P, Visser GH, Schielen PC. Trisomy 18 and 13 screening: consequences for the Dutch Down syndrome screening programme. Prenat Diagn 2010;30:287–9
- Breathnach FM, Malone FD, Lambert-Messerlian G, et al. First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol 2007;110:651–7
- Kagan KO, Wright D, Valencia C, et al. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 2008;23:1968–75
- Kagan KO, Wright D, Maiz N, et al. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;32:488–92
- Wiechec M, Knafel A, Nocun A, et al. How effective is ultrasound-based screening for trisomy 18 without the addition of biochemistry at the time of late first trimester? J Perinat Med 2016;44:149–59
- Wiechec M, Knafel A, Nocun A, et al. How effective is first-trimester screening for trisomy 21 based on ultrasound only? Fetal Diagn Ther 2016;39:105–12
- Wiechec M, Nocun A, Knafel A, et al. Combined screening test for trisomy 21 – is it as efficient as we believe? J Perinat Med 2016. [Epub ahead of print]. doi:10.1515/jpm-2016-0031
- Cicero S, Longo D, Rembouskos G, et al. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects. Ultrasound Obstet Gynecol 2003;22:31–5
- Faiola S, Tsoi E, Huggon IC, et al. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan. Ultrasound Obstet Gynecol 2005;26:22–7
- Huggon IC, Turan O, Allan LD. Doppler assessment of cardiac function at 11-14 weeks’ gestation in fetuses with normal and increased nuchal translucency. Ultrasound Obstet Gynecol 2004;24:390–8
- Wagner P, Sonek J, Hoopmann M, et al. First-trimester screening for trisomy 18, 13, triploidy and Turner syndrome by a detailed early anomaly scan. Ultrasound Obstet Gynecol 2015. [Epub ahead of print]. doi:10.1002/uog.15829
- Sepulveda W, Wong AE, Dezerega V. First-trimester sonographic findings in trisomy 18: a review of 53 cases. Prenat Diagn 2010;30:256–9
- Engels MA, Twisk JW, Blankenstein MA, van Vugt JM. First-trimester screening for down syndrome with serum sampling at different gestational ages: the effect on screening performance. Fetal Diagn Ther 2014;36:293–8
- Spencer K. Screening for Down syndrome. Scand J Clin Lab Invest Suppl 2014;244:41–7
- Valentin M, Muller F, Beaujard MP, et al. First-trimester combined screening for trisomy 21 in women with renal disease. Prenat Diagn 2015;35:244–8